Relmada Therapeutics(RLMD)
$4.21+0.05 (+1.20%)
RLMD
Relmada Therapeutics earnings date
$4.21
At close:+0.05 (+1.20%)
Want to see RLMD full AI Analyst Report?
Relmada Therapeutics (RLMD) Q2 2022 Earnings Report
446 Followers
RLMD Q2 2022 EPS Results
- Actual EPS
- -$1.33
- Consensus EPS
- -$1.27
- Beat/Miss
- Missed by -$0.06
- One Year Ago EPS
- -$1.56
RLMD Q2 2022 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/11/2022
- Time
- After Close
- Conference Call
- Thursday, August 11, 2022
RLMD Upcoming Earnings
Relmada Therapeutics's next earnings date is estimated for March 23, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
RLMD Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 23, 2027 | 2026 (Q4) | -0.13- | -0.27 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -0.14-0.12 | -0.3 | 60.00% (+0.18) | |
| Aug 06, 2026 | 2026 (Q2) | -0.20-0.11 | -0.3 | 63.33% (+0.19) | |
| May 12, 2026 | 2026 (Q1) | -0.20-0.22 | -0.58 | 62.07% (+0.36) | |
| Mar 19, 2026 | 2025 (Q4) | -0.15-0.27 | -0.62 | 56.45% (+0.35) | |
| Nov 13, 2025 | 2025 (Q3) | -0.42-0.30 | -0.72 | 58.33% (+0.42) | |
| Aug 07, 2025 | 2025 (Q2) | -0.46-0.30 | -0.59 | 49.15% (+0.29) | |
| May 12, 2025 | 2025 (Q1) | -0.48-0.58 | -0.72 | 19.44% (+0.14) | |
| Mar 27, 2025 | 2024 (Q4) | -0.67-0.62 | -0.84 | 26.19% (+0.22) | |
| Nov 07, 2024 | 2024 (Q3) | -0.68-0.72 | -0.73 | 1.37% (+0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
